1. Home
  2. Bills
  3. H.R. 427

H.R. 427 · 118th Congress · 2023–2024

SAVE Moms and Babies Act of 2023

H.R. 427 in the 118th Congress (2023–2024) was introduced on Jan 20, 2023, sponsored by Robert E. Latta with 111 co-sponsors.

During the 118th Congress (2023–2024), Joe Biden was president, and Republicans held the House majority and Democrats the Senate majority.

Status
Introduced
Introduced
Jan 20, 2023
Co-sponsors
111
Policy area
Health

What it does

Support And Value Expectant Moms and Babies Act of 2023 or the SAVE Moms and Babies Act of 2023 This bill prohibits the Food and Drug Administration (FDA) from approving any new drug (either as a brand-name drug or a generic) intended to terminate a pregnancy and imposes additional restrictions on such drugs that are already approved.

Summary by the nonpartisan Congressional Research Service.

Sponsor

Robert E. Latta (R-OH). Co-sponsors: 111 Republicans.

Where it stands

  • IntroducedJan 20, 2023
  • Passed the House—
  • Passed the Senate—
  • Sent to the President—
  • Became law—

Latest action: Referred to the Subcommittee on Health. (Jan 27, 2023)

Other Health bills in the 118th Congress

Committees

More

From GovInfo bill records, Congressional Research Service summaries, Voteview roll calls and lobbying reports.

Cite or embed this page

Capitol Receipts, “H.R. 427 (118th Congress): SAVE Moms and Babies Act of 2023,” https://www.capitolreceipts.com/bill/118-hr-427/save-moms-and-babies-act-of-2023 (accessed 2026-10-17).

Open the interactive version ›